Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Braintree Laboratories
Age
12–45
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males or females 12 to 45 years of age with facial acne vulgaris
Qualifying Investigator's Global Assessment severity score
Qualifying number of non-inflammatory lesions
Qualifying number of inflammatory lesions
You may not be if
Facial hair (beard), excessive scarring, sunburn or other disfigurement that may obscure the accurate assessment of acne grade
Using medications that are reported to exacerbate acne
Any clinically relevant finding at their baseline physical examination or dermatological medical history such as severe systemic diseases or diseases of the facial skin
Have a known hypersensitivity or previous allergic reaction to any of the components
Patients who have participated in an investigational clinical, surgical, drug, or device study within the past 30 days
Patients who, in the opinion of the investigator, should not be included in the study for any reason, including inability to follow study procedures
Clareo Health | BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris
